biomedicina slovenica


"Cholesterol" : 701-800

  1. Pišot Rado; Završnik Jernej
    Z gibanjem do zdravja - od otroka do starostnika
    [Being well being physically active - from childhood to the old age]
    2002
  2. Podlesnik Maja; Ravnik Janez; Sok Miha
    Hipoholesterolemija in rak: o serumskem holesterolu še druga plat
    2002
  3. Mavri Alenka; Stegnar Mojca; Sentočnik Jožica T; Videčnik Viktor
    Impact of weight reduction on early carotid atherosclerosis in obese premenopausal women
    2001
  4. Gunde-Cimerman Nina; Plemenitaš Ana
    Hypocholesterolemic activity of the genus Pleurotus (Jacq.:Fr.) P. Kumm. (Agaricales s.l., Basidiomycetes)
    2001
  5. Fon-Tacer K; Haugen TB; Baltsen M; Debeljak N; Rozman D
    Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis-activating sterol (T-MAS)
    2002
  6. Šuput Dušan; Bunc Matjaž; Pavlin Rudolf
    Ateroskleroza
    2001
  7. Anderluh Gregor; Maček Peter
    Cytolytic peptide and protein toxins from sea anemones (Anthozoa: Actiniaria)
    2002
  8. Kastelic Hermina
    Zdravstvena vzgoja bolnikov s hiperholesteremijo in njen pomen
    2001
  9. Slejko Ljiljana
    Dejavniki tveganja in stopnja ogroženosti z boleznimi srca in ožilja
    2001
  10. Bombek Mirko
    K smernicam NCEP-ATP III
    2001
  11. Lauer Michael S; Fontanarosa Phil B
    Posodobljene smernice za uravnavanje ravni holesterola
    [Updated guidelines for cholesterol management]
    2001
  12. Anonymous ;
    Zaključni povzetek tretjega poročila Strokovnega sveta za odkrivanje, opredelitev in zdravljenje visoke ravni holesterola pri odraslih v sklopu Državnega programa izobraževanja o holesterolu. (Smernice za zdravljenje odraslih III)
    [Executive summary of the third report of the National cholesterol education program (NCEP): expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. (Adult treatment panel III)]
    2001
  13. Keber Irena
    Vpliv prehrane na krvne maščobe
    2000
  14. Dalla-Volta Sergio; Anzulović-Mirošević Dinko
    Endothelial dysfunction in heart failure
    2001
  15. Keber Irena
    Heart protection study of statin therapy and of antioxidant supplementation in patients at increased coronary risk
    2001
  16. Žvan Bojana; Zaletel Marjan; Miloševič Zoran; Šurlan Miloš
    Plaques' quality in carotid artery stenting
    2001
  17. Poredoš Pavel
    Endothelial dysfunction in diffuse and distal coronary heart disease
    2001
  18. Rott Tomaž; Koselj Mira; Kern Izidor
    Cholesterol crystal embolism (ChE) - atheroembolism
    2001
  19. Noč Marko
    The role of statins in acute coronary syndrome
    2001
  20. Poredoš Pavel
    Etiopathogenesis of atherosclerosis
    2001
  21. Medvešček Marko
    Preprečevanje zapletov ateroskleroze pri bolnikih s sladkorno boleznijo - pregled prospektivnih študij
    [Prevention of cardiovascular atherosclerotic complications in patients with diabetes - a survey of prospective intervention trials]
    2001
  22. Fon-Tacer K; Debeljak N; Haugen TB; Baltsen M; Rozman D
    Tissue specific expression of lanosterol 14A - demethylase (CYP51) in testis leads to accumulation of cholesterol intermediate
    2001
  23. Cotman Marko; Rozman Damjana; Banek Ljerka; Ježek Davor
    Localisation of lanosterol 14alpha-demethylase in round and elongated sprematids of the mouse testis: an immunoelectron microscopic and stereological study
    2001
  24. Kovačić Dragan; Starc Radovan
    Posebnosti koronarne bolezni pri mladih
    [Specifics of coronary artery disease in young adults]
    2001
  25. Kariž Stojan; Grom Igor; Marušič Tamara
    Sindrom holesterolnih embolizmov - zaplet trombolitičnega zdravljenja pri bolniku z akutnim miokardnim infarktom
    [Cholesterol embolization syndrome - a complication of thrombolytic therapy in a patient with acute myocardial infarction]
    2001
  26. Čakš Tomaž
    Povezanost pušenja s drugim čimbenicima rizika nastanka kroničnih nezarazanih bolesti u stanovnika Ljubljane
    2001
  27. Bombek Mirko
    Smo naredili za preprečevanje bolezni srca in ožilja dovolj? Razširjenost dejavnikov ogrožanja za bolezni srca in ožilja med prebivalci Maribora in okolice
    [Are we doing enough for prevention of cardiopvascular diseases? Distribution of coronary risk factors in population of Maribor region]
    2001
  28. Završnik Matej
    Ateroskleroza in sladkorna bolezen tipa 2
    [Atherosclerosis and diabetes mellitus type 2]
    2001
  29. Vokač Damijan
    Dejavniki tveganja za aterosklerozo
    [Risk factors for atherosclerosis]
    2001
  30. Poredoš Pavel
    Etiopatogeneza ateroskleroze
    [Pathogenesis of atherosclerosis]
    2001
  31. Gajzer Borut; Koželj Miran; Andromako Nikica
    Spontano predrtje žolčnika: prikaz primera
    [Spontaneous gallbladder perforation: a case report]
    2000
  32. Zeng Yong-Hui; Plemenitaš Ana; Linnemann Thomas; Fackler Oliver T; Peterlin B Matija
    Nef increases infectivity of HIV via lipid rafts
    2001
  33. Grad Anton
    Dejavniki tveganja za možganskožilne bolezni
    [Risk factors for cerebrovascular disorders]
    2001
  34. Strmole Darinka
    Prehranjevalne navade in zdravstveno stanje sedmošolcev s povišanim indeksom telesne mase
    [Nutritional habits and healt status of 12-14 years old schoolchildren with increased BMI]
    2001
  35. Mavri Alenka; Gužič-Salobir Barbara; Salobir-Pajnič Barbara; Keber Irena; Stare Janez; Stegnar Mojca
    Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease
    2001
  36. Kotseva K; Wood D; De Backer G; De Bacquer D; Turk J; Keber I; Marn K; Salapura V; Škof E; Špan M
    Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries
    2001
  37. De Backer G; Ambrosio GB; Amouyel P; Cokkinos D; Deckers J; Erhardt L; Graham I; Keber I; Škof E; Špan M
    Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro heart survey programme
    2001
  38. Šebeštjen Miran; Žegura Branka; Gužič-Salobir Barbara; Keber Irena
    Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia
    2001
  39. Vrtovec Bojan; Keber Irena; Gadžijev Andrej; Bardorfer Igor; Keber Dušan
    Carotid intima-media thickness of young coronary patients
    1999
  40. Prešern-Štrukelj Metka
    Rehabilitacija bolnikov po amputaciji spodnjega uda
    [Rehabilitation of patients following the lower limb amputation]
    2001
  41. Petrovič Danijel; Zorc Marjeta; Kanič Vojko; Peterlin Borut
    Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction
    2001
  42. Marušič Andrej
    Factor analysis of risk for coronary heart disease: an independent replication
    2000
  43. Kikelj Danijel
    Novi inhibitorji HMG-CoA-reduktaze
    [Novel inhibitors of HMG-CoA reductase]
    1999
  44. Keber Irena
    Zdravljenje povečane koncentracije krvnih maščob v ambulanti zdravnika družinske medicine
    [Treatment of hyperlipidemia in general practice]
    2001
  45. Hojs Radovan; Koek Tanja
    Nefrotični sindrom in lipoprotein(a)
    [Nephrotic syndrome and lipoprotein(a)]
    2001
  46. Fink Martina; Cotman Marko; Rozman Damjana
    Sterol-dependent and cAMP-dependent regulation of lanosterol 14alpha-demethylase, an enzyme involved in cholesterol biosynthesis
    [Od sterolov odvisno in of cAMP-odvisno uravnavanje izražanja lanosterolne 14alfa-demetilaze, gena, ki kodira encim vključen v biosintezo holesterola]
    2000
  47. Finderle Ž; Cankar K; Šebeštjen M; Keber I
    The effect of fenofibrat and cerivastatin on endothelium dependent and independent vasodilatation
    2000
  48. Žakelj M; Goad JL
    Observations on the biosynthesis of 24methylcholesterol and 24-ethylcholesterol by Zea mays
    1983
  49. Keber I; Keber D; Jurman-Gros T
    Physical training and HDL cholesterol in patients after myocardial infarction
    1983
  50. Gros M; Jurman-Gros T
    HDL-cholesterol in healthy men
    1981
  51. Troncone L; Focacci C; Maussier ML; Falappa PG; Martino F
    RADIOIODOCHOLESTEROL SCINTIGRAPHY IN ADRENAL GLAND TUMORS
    1978
  52. Rott Tomaž; Koselj Mira; Kern Izidor
    Cholesterol embolization in kidney
    1996
  53. Černe Darko; Kaplan-Pavlovčič Staša; Kranjec Igor; Jurgens Gunther
    Mildly elevated serum creatinine concentration correlates with the extent of coronary atherosclerosis
    2000
  54. Petrovič Daniel; Zorc M; Keber I; Peterlin B
    Joint effect of G1691A factor V point mutation and factor VII Arg/Lln353 gene polymorphism on the risk of premature coronary artery disease
    2001
  55. Marušič Andrej
    Psychological factors associated with coronary heart disease
    2000
  56. Petrovič D; Zorc M; Peterlin B
    Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease
    2000
  57. Žegura Branka
    Funkcijske lastnosti arterijske žilne stene, hemostaza in krvni lipidi po peroralnem ali transdermalnem nadomeščanju estrogenov po kirurški menopavzi
    2000
  58. Žegura B; Šebeštjen M; Keber I; Videčnik V
    Carotid intima-media thickness in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia
    1999
  59. Šebeštjen M; Žegura B; Gužič-Salobir B; Keber I
    The role cardiovascular dymetabolic syndrome in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia
    1999
  60. Keber I; Šebeštjen M; Žegura B; Videčnik V; Keber D
    Odnos ateroskleroze karotidnih arterija i infarkta miokarda u bolesnika sa porodičnom hiperkolesterolemijom prema lipoproteinu (a) i čimbenicama fibrinolize
    [Relation of carotid atherosclerosis and myocardial infarction in patients with familial hypercholesterolemia to lipoprotein (a) and fibrinolytic factors]
    1997
  61. Keber I; Žegura B; Šebeštjen M; Keber D
    Atherogenic and thrombogenic risk factors in patients with familial hypercholesterolemia and symptomatic coronary artery disease
    1996
  62. Keber I; Šebeštjen M; Žegura B; Lavrenčič A; Kosmina B; Videčnik V
    Relation of lipoprotein (a) to carotid artery wall morphology: ultrasound study in patients with familial hypercholesterolemia
    1997
  63. Videčnik V; Keber I; Šebeštjen M; Žegura B; Keber D
    Carotid arterial wall changes in patients with familial hypercholesterolemia
    1996
  64. Božič Mojca; Stegnar Mojca; Fermo Isabella; Ritonja Anka; Peternel Polona; Stare Janez; D'Angelo Armando
    Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
    2000
  65. Fidler Nataša
    Vpliv viskoznosti črevesne vsebine na absorpcijo hranil
    [The influence of viscosity of intestinal content on nutrient absorption]
    1995
  66. Maučec-Zakotnik Jožica
    Ogroženost Slovencev z dejavniki tveganja za kardiovaskularne in druge kronične bolezni: vloga države in mesto zdravstvene službe v prizadevanjih za boljše zdravje Slovencev
    2000
  67. Maučec-Zakotnik Jožica
    Vloga države pri izvajanju prehranske politike z vidika varovanja zdravja
    2000
  68. Debeljak Nataša; Majdič Gregor; Haugen Trine B; Waterman Michael R; Rozman Damjana
    Why is cholesterogenic lanosterol 14alpha-demethylase (CYP51) highly expressed in germ cells of the testis?
    2000
  69. Majdič G; Parvinen M; Bellamine A; Harwood HJ; Ku WW; Waterman MR; Rozman D
    Lanosterol 14alpha-demethylase (CYP51), NADPH-cytochrome P450 reductase and squalene synthase in spermatogenesis: late spermatids of the rat express proteins needed to synthesize follicular fluid meiosis activating sterol
    2000
  70. Fink Martina
    Odziv človeškega gena za lanosterolno 14alfa-demetilazo na cAMP odvisno in od sterolov odvisno uravnavanje
    2000
  71. Boh M; Šebeštjen M; Keber I
    No difference in improvement of flow mediated dilation after simvastatin or pravastatin in males with hypercholesterolemia
    2000
  72. Borovničar A; Keber I; Kragelj-Zaletel L
    Effect of vitamin on endothelial function and carotid intima-media thickness in males with hypercholesterolemia
    2000
  73. Česnik Ardea
    Povečana koncentracija holesterola v plazmi in spremljajoči dejavniki tveganja v ambulanti splošnega zdravnika
    [The raised cholesterol level in the plasma and the accompanying risk factors identified at the general practitioner's]
    2000
  74. Borovničar Alenka; Keber Irena; Stavljenić-Rukavina Ana; Zaletel-Kragelj Lijana
    Improvement of early functional atherosclerotic changes in males with hypercholesterolemia after vitamin E supplementation
    2000
  75. Maučec-Zakotnik Jožica
    Kako so se v šestih letih spremenili dejavniki tveganja za kronične bolezni. (Primerjava CINDI vzorcev Ljubljančanov 1990/97)
    2000
  76. Prelog I; Krajnc I; Lukanovič K
    Treatment of psoriatic arthritis with cyclosporin A
    2000
  77. Koek Tanja; Hojs Radovan
    Lipoprotein (A) pri bolnikih z nefrotičnim sindromom
    [Lipoprotein (A) in patients with nephrotic syndrome]
    2000
  78. Černe Darko; Kaplan-Pavlovčič Staša; Kranjec Igor; Jurgens Gunther
    Mildly elevated serum creatinine concentration correlates with the extent of coronary atherosclerosis
    2000
  79. Debeljak N; Rassoulzadegan M; Cuzin F; Rozman D
    Mouse as a model to study the "in vivo" role of lanosterol 14alpha-demethylase and meiosis activating sterols in spermatogenesis
    2000
  80. Chabova V; Tesar V; Žabka J; Rychlik I; Merta M; Jirsa M Jr; Stejskalova A; Stejskal J
    Long term treatment of IgA nephropaty with cyclosporine A - a preliminary report
    2000
  81. Keber Irena
    Aterosklerozo povzroča splet dednih dejavnikov in nezdravih razvad - predvsem kajenje in hrana
    1998
  82. Šebeštjen Miran
    Vpliv statinov in fibratov na funkcionalne in morfološke lastnosti arterijske stene pri bolnikih s kombinirano hiperlipidemijo
    2000
  83. Keber Irena
    Abdominalna (viscelarna) debelost in koronarna bolezen srca pri ženskah: slovenski komentar
    2000
  84. Borovničar A; Keber I
    Vpliv antioksidanta na funkcijske in morfološke spremembe arterijske stene pri osebah s hiperholesterolemijo
    1999
  85. Fras Z
    Dislipidemije in sodobna preventiva ateroskleroze
    1999
  86. Poredoš Pavel; Kek Anita
    Relation of blunted dilation of the brachial artery in insulin-dependent diabetes mellitus to microalbuminuria
    2000
  87. Štupar Janez; Vrtovec Matjaž; Kocijančič Andreja; Gantar Anton
    Chromium status of tannery workers in relation to metabolic disorders
    1999
  88. Boh Marko
    Pomen holesterola HDL v normalnih in bolezenskih okoliščinah ter zdravljenje hipoalfalipoproteinemije
    [The significance of HDL cholesterol in health and disease, and therapy of hypoalphalipoproteinemia]
    2000
  89. Prešeren Nada
    Holesterol in nasičene maščobne kisline
    1996
  90. Erjavec Tatjana
    Risk factors and atherosclerosis in patients with spinal cord lesions
    2000
  91. Šebeštjen M; Žegura B; Gužič-Salobir B; Keber I
    Inzulinska rezistenca in zmanjšana fibrinolitična aktivnost: označevalca prebolelega miokardnega infarkta pri bolnikih s heterozigotno družinsko hiperholesterolemijo
    1999
  92. Poredoš Pavel
    Regarding "Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction": in response reply to Dr. Milionis et al
    1999
  93. Plemenitaš Ana; Watson John A
    Down-regulation of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with highly purified liposomal cholesterol
    1999
  94. Kržišnik C; Battelino T
    Vpiv prehrane na rast in razvoj otrok in mladostnikov
    [The role of nutrition in growth and development of children and adolescents]
    1998
  95. Kovač Damjan
    Zdravljenje hiperlipidemije z lovastatinom pri bolnikih s presajeno ledvico in ciklosporinsko imunosupresijo
    1994
  96. Bratanič Borut
    Vpliv dojenja na kasnejše presnovne značilnosti
    2000
  97. Pokorn Dražigost
    Pomen maščob v prehrani
    1999
  98. Pavlin Rudi
    Statini in ubikinon (koencim Q10)
    [Statins and ubiquinone (coenzyme Q10)]
    2000
  99. Rakovec Peter; Bizjak Mojca; Verhovec Maja
    Diete za hujšanje, zmanjšanje holesterola in krvnega tlaka
    1999
  100. Šentjurc M; Kočevar K; Honzak L
    Role of cholesterol in the transport of liposome encapsulated substances into the skin
    1996

   1 101 201 301 401 501 601 701 801 901  


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko